Analytical Data
-
Gene name
Prl3d1
- Application
-
Alternative Names
Chorionic somatomammotropin hormone 1 Placental lactogen I
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P18121
-
Expression Region
30-224aa
-
Molecular Weight
26.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Prl3d1, a member of the Prl (pregnancy-specific glycoprotein) gene family, has garnered significant attention due to its unique expression patterns and potential roles in various biological processes. Originally identified in the context of placental development, Prl3d1 is predominantly expressed in trophoblast cells, playing critical roles during pregnancy. Recent studies have suggested that Prl3d1 may be involved in modulating immune responses, facilitating maternal-fetal interactions, and influencing cell proliferation and differentiation. Additionally, its involvement in pathological conditions such as cancer has been proposed, as altered levels of Prl3d1 expression have been observed in various tumors. Researchers are increasingly focused on the recombinant production of Prl3d1 protein to elucidate its functional mechanisms and therapeutic potential. By developing recombinant Prl3d1, scientists aim to investigate its biochemical properties, receptor interactions, and downstream signaling pathways. Moreover, understanding the molecular characteristics of Prl3d1 can open avenues for novel diagnostic and therapeutic strategies, particularly in reproductive health and oncology. The exploration of Prl3d1's structure-function relationship through recombinant protein studies is crucial for advancing our knowledge of its biological significance and therapeutic applications.
